Cheektowaga, NY, United States of America

Manivannan Ethirajan

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Health Research, Inc., Photolitec, LLC, Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manivannan Ethirajan. Retrieved from https://idiyas.com/inventor/manivannan-ethirajan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Buffalo, NY (US) (2015)
  • Cheektowaga, NY (US) (2016 - 2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Manivannan Ethirajan**

Introduction

Manivannan Ethirajan, based in Cheektowaga, NY, is a distinguished inventor with a remarkable portfolio that includes three patents. His innovative work primarily focuses on advancements in photodynamic therapy and cancer treatment, showcasing his dedication to improving medical technologies.

Latest Patents

Ethirajan's latest patents demonstrate his expertise and ingenuity in the field. One of his prominent inventions is a cyanine dye compound and a preparation method therefor. This invention provides a cyanine dye compound connected to multiple markers, which significantly enhances the accuracy of the dye's combination with tumor cells. This improvement effectively reduces background values and mitigates excessive residue in the liver. Furthermore, Ethirajan has developed a dual-function agent for photodynamic therapy, which also includes a preparation method. The cyanine dye compound in this invention is conjugated with a photosensitizer at the 2'′ position, promoting high levels of absorption by tumor cells. Additionally, Ethirajan has worked on kinase protein binding inhibitors, which are crucial in identifying and using protein binding inhibitor compounds for treating cell proliferative disorders, particularly cancer.

Career Highlights

Throughout his career, Manivannan Ethirajan has collaborated with prominent companies, notably Zhejiang Hisun Pharmaceutical Co., Ltd., and Photolitec, LLC. His innovative contributions have played a vital role in the development of new pharmaceutical compositions that target various health disorders.

Collaborations

Ethirajan has collaborated with talented professionals like Ravindra K. Pandey and Nayan Patel. These partnerships have facilitated the advancement of new ideas and technologies, further pushing the boundaries in the medical field.

Conclusion

In summary, Manivannan Ethirajan's contributions to the field of medical innovation through his patents reflect a significant commitment to enhancing treatment methodologies, particularly in cancer care. His work not only showcases his exceptional inventiveness but also his desire to improve patient outcomes through advanced therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…